DNA hypomethylation leads to elevated mutation rates

Area of Science:

• Genetics
• Epigenetics
• Cancer Biology

Background:

• Global DNA hypomethylation is observed in tumor cells and linked to genomic instability.
• Defects in DNA methylation may contribute to colorectal tumor cell line instability.
• Hypomethylation is associated with chromosomal abnormalities in ICF syndrome and with demethylating agents.

Purpose of the Study:

• To investigate the role of DNA methylation in maintaining genome stability.
• To determine the mutation rates in cells lacking major DNA methyltransferase (Dnmt1).

Main Methods:

• Generated murine embryonic stem cells nullizygous for the Dnmt1 gene.
• Assessed mutation rates at the endogenous hypoxanthine phosphoribosyltransferase (Hprt) gene and a viral thymidine kinase (tk) transgene.
• Analyzed the types of mutations, including gene deletions, mitotic recombination, and chromosomal loss.

Main Results:

• Dnmt1-deficient murine embryonic stem cells showed significantly elevated mutation rates at both Hprt and tk loci.
• Gene deletions were the predominant mutation type observed.
• Mitotic recombination or chromosomal loss with duplication were the major causes of tk deletions.

Conclusions:

• Mammalian DNA methylation, specifically via Dnmt1, plays a crucial role in maintaining genome stability.
• Loss of DNA methylation can lead to increased mutation rates and chromosomal instability.
• These findings support the hypothesis that genome-wide demethylation contributes to carcinogenesis.